LIB Therapeutics LLC Report issue

For profit Phase 3
Founded: Cincinnati OH United States (2017)

Organization Overview

First Clinical Trial
2017
NCT03545438
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

LIB Therapeutics | LIB Therapeutics LLC